Chief Medical Officer, Interventional Cardiology (IC)

Boston Scientific•Maple Grove, MN

6d•$450,000 - $500,000

About The Position

The Chief Medical Officer (CMO), Interventional Cardiology (IC) will contribute to the strategic direction of the IC division by ensuring the clinical and medical viability of the current product portfolio and therapeutic pipeline. This role provides scientific leadership and clinical expertise to support the design, execution and analysis of clinical studies while overseeing the clinical benefit-risk profile of the business. The CMO will serve as a strategic advisor to executive leadership, helping shape innovation priorities, evidence-generation strategies and external scientific engagement across the division. Boston Scientific was recognized as a Glassdoor Best Place to Work in 2026, ranking No. 15 on the Top 100 list, reflecting the culture our employees experience every day.

Requirements

Minimum degree of Doctor of Medicine (M.D.) is required.
Minimum of 15 years' experience in the field of cardiology is required, including specific experience within Coronary Therapies and Structural Heart Valves.

Nice To Haves

Experience in Interventional Heart Failure is desired.

Responsibilities

Collaborate with IC business leaders to understand and inform divisional priorities, clinical strategies and long-term growth objectives.
Develop and implement a division-level medical strategy aligned with business goals, including portfolio prioritization, process optimization and stakeholder engagement.
Provide executive-level medical and therapeutic leadership to internal and external stakeholders, including project teams, investigators, healthcare providers and regulatory agencies.
Contribute to technology and innovation strategy, including evaluation of internal and external technologies, partnerships and acquisitions to support future product development and market expansion.
Deliver medical insights throughout the product lifecycle, from early-stage innovation and clinical development through commercialization and post-market surveillance.
Review regulatory submissions and represent Boston Scientific in interactions with global regulatory agencies, including the U.S. Food and Drug Administration and international health authorities.
Provide clinical expertise to guide study design, evidence-generation strategies and interpretation of clinical data to support product approvals and market adoption.
Integrate emerging scientific and clinical findings into divisional strategy and product development efforts.
Participate in and support medical education initiatives, advisory boards and scientific exchange activities.
Represent the company at scientific congresses, industry associations and key medical forums.
Present and communicate clinical evidence and study outcomes to the scientific and medical communities.
Serve as a spokesperson in engagements with healthcare professionals, regulators, patient advocacy organizations, academic institutions and investors.
Build and strengthen relationships with Key Opinion Leaders across relevant therapeutic and procedural specialties.
Foster strategic scientific collaborations with research organizations, healthcare systems and industry partners to advance innovation and clinical evidence generation.
Lead medical oversight for IC, prioritizing patient safety and clinical integrity across all development and commercial activities.
Monitor adverse events and emerging safety signals and implement risk management strategies as appropriate.
Partner cross-functionally to ensure accurate adverse event reporting and ongoing benefit-risk assessments for marketed and investigational products.
In all actions, demonstrates a primary commitment to patient safety and product quality by maintaining compliance to the Boston Scientific Quality Policy and all other documented quality processes and procedures.
Assures that appropriate resources (personnel, tools, etc.) are maintained to ensure Quality System compliance and adherence to the Boston Scientific Quality Policy.
Establishes and promotes a work environment that supports the Quality Policy and Quality System.
Learn the IC culture and contribute positively to it with peers and direct reports.
Lead and develop high-performing global medical and clinical teams to achieve organizational objectives.
Foster a diverse and inclusive workplace that enables employees to contribute to their full potential in pursuit of organizational goals.
Oversee budgets, resource planning and operational activities across areas of responsibility.
Ensure compliance with company policies, regulatory requirements and ethical standards.
Responsible, through vice president-level leadership, for global medical affairs, clinical and scientific functions supporting major divisional operations.
Define organizational structures, establish strategic priorities and delegate leadership responsibilities across teams and geographies.
Oversee strategic management and operational execution across key IC business segments.
Monitor clinical, operational and market trends to assess progress, manage risks and identify opportunities for growth.
Identify and evaluate new business opportunities, strategic partnerships and acquisition targets.
Participate as a member of diligence teams supporting potential IC investments, partnerships and acquisitions.
Advance the value of clinical and scientific expertise to support IC’s mission of delivering meaningful innovation to patients and physicians.
Drive evidence-based decision-making and streamline processes that enhance medical education, physician engagement and patient outcomes.
Serve as a principal medical spokesperson on critical matters impacting the global IC division and broader enterprise initiatives.